As NJ awaits first delivery of COVID-19 vaccine, concern over ‘vaccine hesitancy’

Polls: Just 60% of NJ residents would get a vaccine that's ‘safe and effective’

As Pfizer’s COVID-19 vaccine awaits final approval by the Food and Drug Administration, polls show that just 60% of New Jersey residents would get a vaccine that’s “safe and effective.” Rutgers Dean Perry Halkitis says that the Achilles heel in terms of curtailing the coronavirus pandemic could be “vaccine hesitancy.”

Once the FDA gives its final authorization of Pfizer’s vaccine, that will set in motion the largest vaccination effort in U.S. history. Six hospitals in New Jersey are poised to receive the first doses 24 to 48 hours after that approval, according to the state Department of Health. The state is ready to begin vaccinating 70% of the adult population next week but as those first inoculations get closer, are residents ready to roll up their sleeves? Senior Correspondent Brenda Flanagan reports.

We’re in this together
For a better-informed future. Support our nonprofit newsroom.
Donate to NJ Spotlight